TCM
PFE icon

Towercrest Capital Management’s Pfizer PFE Stock Holding History

Towercrest Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
+10,599
New +$277K 0.04% 95
2025
Q1 		– Sell
-15,107
Closed -$401K – 98
2024
Q4 		$401K Hold
15,107
– – 0.06% 77
2024
Q3 		$437K Hold
15,107
– – 0.07% 76
2024
Q2 		$423K Buy
15,107
+100
+0.7% +$2.75K 0.07% 79
2024
Q1 		$416K Buy
15,007
+1,689
+13% +$46.9K 0.07% 79
2023
Q4 		$383K Buy
13,318
+2,382
+22% +$72K 0.07% 80
2023
Q3 		$363K Buy
10,936
+270
+3% +$9.55K 0.07% 80
2023
Q2 		$391K Buy
10,666
+3,925
+58% +$153K 0.07% 75
2023
Q1 		$275K Sell
6,741
-500
-7% -$21.6K 0.06% 81
2022
Q4 		$371K Hold
7,241
– – 0.08% 67
2022
Q3 		$317K Buy
7,241
+25
+0.3% +$1.22K 0.07% 69
2022
Q2 		$378K Hold
7,216
– – 0.08% 64
2022
Q1 		$374K Buy
7,216
+400
+6% +$20.8K 0.07% 70
2021
Q4 		$403K Sell
6,816
-51
-0.7% -$2.53K 0.07% 67
2021
Q3 		$295K Sell
6,867
-79
-1% -$3.5K 0.06% 75
2021
Q2 		$272K Sell
6,946
-166
-2% -$6.46K 0.05% 77
2021
Q1 		$258K Sell
7,112
-834
-10% -$29.6K 0.06% 77
2020
Q4 		$293K Buy
7,946
+647
+9% +$23.7K 0.07% 72
2020
Q3 		$254K Buy
7,299
+280
+4% +$9.82K 0.06% 71
2020
Q2 		$218K Hold
7,019
– – 0.06% 75
2020
Q1 		$217K Sell
7,019
-402
-5% -$13.7K 0.07% 73
2019
Q4 		$276K Buy
7,421
+124
+2% +$4.42K 0.07% 71
2019
Q3 		$249K Hold
7,297
– – 0.07% 65
2019
Q2 		$299K Buy
7,297
+432
+6% +$17.2K 0.08% 61
2019
Q1 		$276K Buy
6,865
+212
+3% +$8.49K 0.08% 59
2018
Q4 		$276K Buy
6,653
+27
+0.4% +$1.12K 0.09% 59
2018
Q3 		$277K Buy
+6,626
New +$255K 0.08% 64

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Towercrest Capital Management's PFE Position: Q2 2026 in Review

Towercrest Capital Management opened a new position in Pfizer (PFE) in Q2 2026: 10,599 shares worth $255K. The stake represents 0.04% of the portfolio and ranks #95 among its holdings. This is a return to the name: Towercrest Capital Management previously reported a position in PFE as recently as Q4 2024.

Towercrest Capital Management first reported a position in PFE in Q3 2018 and has held it in 27 quarters since. The position peaked at $437K in Q3 2024. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Towercrest Capital Management held 10,599 shares of Pfizer worth $255K as of Q2 2026.
  • Pfizer was a new Towercrest Capital Management position in Q2 2026.
  • Pfizer made up 0.04% of Towercrest Capital Management's portfolio in Q2 2026, its #95 holding.
  • Towercrest Capital Management first reported a position in Pfizer in Q3 2018 and has held it in 27 quarters since.
  • Towercrest Capital Management's Pfizer position peaked at $437K in Q3 2024.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Towercrest Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.